Search Results

Daxor Corporation announces today it will be exhibiting at the MedAxiom CV Transforum Spring’24 Conference being held at the Atlanta Marriott Marquis in GA, from April 18-20, 2024.

Daxor Corporation, the global leader in blood volume measurement technology, announces it will be exhibiting at the MedAxiom CV Transforum Fall’23 Conference being held at the JW Marriott in Austin, TX from October 5-7, 2023.

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will be exhibiting at the MedAxiom CV Transforum Spring’23 Conference being held at the Renaissance Orlando at SeaWorld in Orlando, FL from April 20-22, 2023.

Daxor Corporation announces today it has entered into an industry partnership with MedAxiom.

Daxor Corporation announces Daxor’s BVA-100 diagnostic will be featured in a MedAxiom Academy webinar - Best Practices for Using Blood Volume Analysis to Reduce Heart Failure LOS, Readmissions, Mortality and Costs on November 17, 2022, at 1pm ET.

HealthTech Arkansas and MedAxiom have come together to create HeartX, a cardiovascular-focused healthcare accelerator, to facilitate guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market.

Daxor Corporation, the global leader in blood volume measurement technology, announces it will be exhibiting for the first time at the MedAxiom CV Transforum Fall’22 Conference being held at the JW Marriott in Austin, TX from October 6-8, 2022.

MedAxiom, the nation’s leading cardiovascular healthcare membership organization and performance community, is excited to announce its industry partnership with Vector Remote Care, a complete cardiac remote monitoring solution that makes it simple for cardiac care teams to accurately capture, manage, analyze and act on the growing volume of remote cardiac data.

HeartFlow, Inc., a leader in revolutionizing precision heartcare, and MedAxiom, an American College of Cardiology (ACC) company whose mission is to transform cardiovascular care and improve heart health, announced today a collaboration to improve cardiovascular care for patients with coronary artery disease (CAD